Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins

Objective Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated enzyme, that has been implicated as a biomarker of cardiovascular risk in patients with rheumatoid arthritis (RA). We aimed to investigate how different biologic therapies affect levels of PON1 and oxylipins.Methods 1213 a...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jeffrey R Curtis, Jennifer Wang, Joel M Kremer, Srinivasa T Reddy, Dimitrios A Pappas, Christina Charles-Schoeman, David A Elashoff, Rong Guo, Amir A Razmjou, Ani Shahbazian, David Meriwether, Dawoud Sulaiman, Ellen O'Connor
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 2024-10-01
Series:	RMD Open
Acceso en liña:	https://rmdopen.bmj.com/content/10/4/e004829.full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!